Wenzhou-Medical-University on Bioeconhttps://en.bioecon.ru/companies/wenzhou-medical-university/Recent content in Wenzhou-Medical-University on BioeconHugoen-USSat, 11 Jul 2026 14:19:14 +0700Base editinghttps://en.bioecon.ru/technology/base-editing/Fri, 19 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/base-editing/Base editors (CBE/ABE) make single-nucleotide changes C·G→T·A and A·T→G·C without double-strand breaks — treating monogenic disease (sickle cell, beta-thalassemia) at up to 90% efficiency with no indels.